Publications by authors named "Julia Fleck"

Claim this Profile
R
RareLink: scalable REDCap-based framework for rare disease interoperability linking international registries to FHIR and Phenopackets.
Adam S L Graefe, Filip Rehburg, Samer Alkarkoukly, Daniel Danis, Ana Grönke, Julia Fleck

NPJ Genom Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking international registries to FHIR and Phenopackets with RareLink: a scalable REDCap-based framework for rare disease data interoperability.
Adam S L Graefe, Filip Rehburg, Samer Alkarkoukly, Daniel Danis, Ana Grönke, Julia Fleck

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence in transfusion medicine: a paradigm shift on the horizon.
Fabrice Cognasse, Stéphane Avril, Julia L Fleck, Hind Hamzeh-Cognasse

Blood Transfus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learned.
Michele Zoch, Christian Gierschner, Anne-Katrin Andreeff, Elisa Henke, Martin Sedlmayr, Julia Fleck

Digit Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting drug sensitivity of cancer cells based on DNA methylation levels.
Sofia P Miranda, Fernanda A Baião, Julia L Fleck, Stephen R Piccolo

PLoS One· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of deep molecular response in chronic myeloid leukemia using supervised machine learning models.
Zahra Zad, Simone Bonecker, Taiyao Wang, Ilana Zalcberg, Gustavo T Stelzer, Julia L Fleck

Leuk Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
Gabriela Sarti Kinker, Glauco Akelinghton Freire Vitiello, Ariane Barros Diniz, Mariela Pires Cabral-Piccin, Pedro Henrique Barbosa Pereira, Julia Lima Fleck

Gut· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant therapeutic strategy decision support for an elderly population with localized breast cancer: A monocentric cohort retrospective study.
Julia L Fleck, Daniëlle Hooijenga, Raksmey Phan, Xiaolan Xie, Vincent Augusto

PLoS One· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The medical informatics initiative and rare diseases: next-generation routine data for diagnosis, therapy selection and research].
Josef Schepers, Julia Fleck, Jannik Schaaf

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-Driven Identification of Biomarkers for In Situ Monitoring of Drug Treatment in Bladder Cancer Organoids.
Lucas Becker, Felix Fischer, Julia L Fleck, Niklas Harland, Alois Herkommer

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological and socioeconomic characteristics predict COVID-19 mortality and resource utilization in Brazil.
Salomón Wollenstein-Betech, Amanda A B Silva, Julia L Fleck, Christos G Cassandras, Ioannis Ch Paschalidis

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-cancer analysis of progression mechanisms and drug sensitivity in cancer cell lines.
Julia L Fleck, Ana B Pavel, Christos G Cassandras

Mol Omics· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No-shows in appointment scheduling - a systematic literature review.
Leila F Dantas, Julia L Fleck, Fernando L Cyrino Oliveira, Silvio Hamacher

Health Policy· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating mutation and gene expression cross-sectional data to infer cancer progression.
Julia L Fleck, Ana B Pavel, Christos G Cassandras

BMC Syst Biol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis